Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CODEXIS, INC. Director's Dealing 2019

Mar 22, 2019

33607_dirs_2019-03-22_5852775a-e22f-49f1-ba5a-1209d50ecfd6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CODEXIS INC (CDXS)
CIK: 0001200375
Period of Report: 2019-03-20

Reporting Person: SANGSTER GORDON (SVP & Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-03-20 Common Stock M 40000 $3.39 Acquired 174453 Direct
2019-03-20 Common Stock S 40000 $20.8503 Disposed 134453 Direct
2019-03-21 Common Stock M 40000 $4.10 Acquired 174453 Direct
2019-03-21 Common Stock S 40000 $20.9051 Disposed 134453 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-03-20 Stock Option (Right to Buy) $3.39 M 40000 Acquired 2025-02-10 Common Stock (40000) Direct
2019-03-21 Stock Option (Right to Buy) $4.1 M 40000 Acquired 2026-02-18 Common Stock (40000) Direct

Footnotes

F1: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 28, 2018.

F2: This transaction was executed in multiple trades in prices ranging from $20.53 to $21.13, inclusive. The price report in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F3: This transaction was executed in multiple trades in prices ranging from $20.73 to $21.24, inclusive. The price report in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F4: Option is fully vested and exercisable.

F5: Option currently vests monthly, such that the option will be fully vested and exercisable on February 19, 2020.